Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
about
Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?Polycyclic aromatic hydrocarbon biomarkers and serum markers of inflammation. A positive association that is more evident in menExposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayersHypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritisPeriodontal disease as a specific, albeit chronic, infection: diagnosis and treatmentSystemic diseases caused by oral infectionRosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveJupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?Pleiotropic effects of statinsGenetic Loci associated with C-reactive protein levels and risk of coronary heart diseaseC-reactive protein: a critical updateChronic stress and age-related increases in the proinflammatory cytokine IL-6Rising statin use and effect on ischemic stroke outcomeAre statins anti-inflammatory?Diagnostic strategies for C-reactive protein.The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery diseaseIs the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritisFrom C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for AtheroprotectionAnticoagulants and Statins As Pharmacological Agents in Free Flap Surgery: Current RationaleInfluence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virusThe influence of anti-infective periodontal treatment on C-reactive protein: a systematic review and meta-analysis of randomized controlled trialsC-reactive protein and coronary heart disease: all said--is not it?The role of oxidative stress and inflammation in cardiovascular agingTestosterone and the cardiovascular system: a comprehensive review of the clinical literatureBiomarkers for strokeTargeting interleukin-1 in heart diseaseMass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular diseaseAction mechanism and cardiovascular effect of anthocyanins: a systematic review of animal and human studiesCoronary artery calcium screening: does it perform better than other cardiovascular risk stratification tools?C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adultsC-reactive protein, antiinflammatory drugs, and quality of life in diabetesRole of C-reactive protein in cardiovascular diseaseReduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factorTreatment of metabolic syndromeTrends in the care of patients with acute myocardial infarction at a university-affiliated Veterans Affairs Medical CenterC-reactive protein, cardiovascular disease and stroke: new roles for an old biomarkerRelations of plasma high-sensitivity C-reactive protein to various cardiovascular risk factorsSystematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease
P2860
Q22241777-6890C407-66A0-4045-9C64-C33D1D14200DQ23918985-229C6A88-C27F-4746-86AF-AC1342EAB3FDQ23923104-01DC809D-4A01-4FD7-8C28-828655627307Q24242787-A848C0C5-8366-4D7D-85D5-EEBE320A62C7Q24550679-6C319E04-FDAB-4B59-9544-6C7CD037417CQ24550707-1522DDF5-BE36-4786-8429-26093B3872EAQ24594814-68ADBBAB-5F70-4DA8-AEE8-7782E2B39632Q24630160-85569AE8-C0A3-4CAC-A028-0308E36190C4Q24647863-5C9C7982-C829-4675-A0A5-D220A6D70780Q24649709-90D9BCDE-41AF-4884-A3A5-3193334836A6Q24672855-BBB7D5EC-3324-4300-9405-D88E7506CDA2Q24678400-9004BFE8-84A2-498B-903F-9AB37F14458BQ24792305-CB2202E7-783B-4CA6-B83C-8111D9EA2601Q24792912-3562D725-ED29-408C-94A3-379297D3A348Q24794260-C5B24E8C-BB93-4CB3-906B-320C9D1C66F9Q24794673-9E9BADE9-C430-40A0-81FE-BC715C071603Q24796491-CA63E068-B60A-4927-A2C3-671F4003E18CQ25255535-6358356D-DA57-4499-BDB3-74AEFE5714A6Q26746659-261FECE6-BFEE-40AE-B4EF-8CCE907E4E6AQ26770209-05447061-FCC6-4EBC-A0F3-9F4BFD795C6BQ26776077-CDC32C76-8C8D-4F68-AC6B-FC6BA858F7BDQ26851535-225C8B5C-7729-4973-B316-1A2AEC284B2FQ26853062-E665C0FF-F40E-49AA-85E7-3780B2EEF010Q26860959-208C08AB-396D-48D6-956D-61CA597A9146Q26864987-3E7E1792-FD97-4E4D-893C-BB789E60D31FQ27000507-FC2C930E-C838-4ABC-8A1D-1ADABE2BC628Q27004404-0589798A-0C1F-4DC8-9580-346700BB4C65Q27009347-776958D6-6E26-4C24-AC05-FCB53480D848Q28075372-17CD1F5B-F595-4FA4-BB88-FE8D232F63DFQ28077812-5A3653B2-29CD-43D5-BE51-6F1E61E16DF8Q28084909-D6E28608-4589-4F6D-BA47-E2312985A772Q28165182-BFE50219-ED9E-4AB3-B6EF-10BDC8C4BD63Q28165737-E929449C-F13A-4C1B-8D7F-83763BBA0441Q28166927-323B7DD0-5736-4459-8E21-EE75FC76C8B6Q28167780-90BCE4FB-4D79-4542-9248-57004A0552AAQ28168652-D389C485-B498-4B90-9536-C0E42C4D2442Q28174000-23EA7570-F442-498A-A5BD-91672AC7D580Q28174368-78AF98A0-CA0A-49B0-BE79-730A15231385Q28177167-F40E2D50-B969-4C8B-9748-891DA820AA96Q28185314-AE4D87C3-B906-4E84-AE93-8D80F2BE5AC9
P2860
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
@ast
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
@en
type
label
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
@ast
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
@en
prefLabel
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
@ast
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
@en
P2093
P921
P3181
P1476
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
@en
P2093
Hennekens CH
Stampfer MJ
P3181
P356
10.1056/NEJM199704033361401
P407
P577
1997-04-03T00:00:00Z